Skip to content

clinical efficacy of NV-21X (usefulness of material removal in the vicinity of 30,000 dalton molecular weight)

clinical efficacy of NV-21X (usefulness of material removal in the vicinity of 30,000 dalton molecular weight) - clinical efficacy of NV-21X

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007969
Enrollment
1
Registered
2012-05-21
Start date
2012-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis chronic renal failure

Interventions

clinical efficacy of NV-21X

Sponsors

sanko clinics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: long-time dialysis patients with joint pain in multiple places

Exclusion criteria

Exclusion criteria: long-time dialysis patients without joint pain

Design outcomes

Primary

MeasureTime frame
A1-Mg,B2-Mg,albumin

Countries

Japan

Contacts

Public Contactseiya takamoto

sanko clinics dialysis unit division engineer

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026